IL125622A - Erythromycin derivatives, method for preparing same and pharmaceutical compositions comprising them - Google Patents

Erythromycin derivatives, method for preparing same and pharmaceutical compositions comprising them

Info

Publication number
IL125622A
IL125622A IL12562297A IL12562297A IL125622A IL 125622 A IL125622 A IL 125622A IL 12562297 A IL12562297 A IL 12562297A IL 12562297 A IL12562297 A IL 12562297A IL 125622 A IL125622 A IL 125622A
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
preparing same
erythromycin derivatives
erythromycin
derivatives
Prior art date
Application number
IL12562297A
Other languages
English (en)
Other versions
IL125622A0 (en
Inventor
Jean-Francois Chantot
Constantin Agouridas
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL125622A0 publication Critical patent/IL125622A0/xx
Publication of IL125622A publication Critical patent/IL125622A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL12562297A 1996-02-28 1997-02-27 Erythromycin derivatives, method for preparing same and pharmaceutical compositions comprising them IL125622A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602472A FR2745290B1 (fr) 1996-02-28 1996-02-28 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
PCT/FR1997/000351 WO1997031929A1 (fr) 1996-02-28 1997-02-27 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
IL125622A0 IL125622A0 (en) 1999-04-11
IL125622A true IL125622A (en) 2003-10-31

Family

ID=9489659

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12562297A IL125622A (en) 1996-02-28 1997-02-27 Erythromycin derivatives, method for preparing same and pharmaceutical compositions comprising them

Country Status (31)

Country Link
US (1) US6096714A (ko)
EP (1) EP0885234B1 (ko)
JP (1) JP4102440B2 (ko)
KR (1) KR100486053B1 (ko)
CN (1) CN1168734C (ko)
AP (1) AP952A (ko)
AR (1) AR005999A1 (ko)
AT (1) ATE217633T1 (ko)
AU (1) AU716204B2 (ko)
BG (1) BG63207B1 (ko)
BR (1) BR9707709B1 (ko)
CZ (1) CZ293893B6 (ko)
DE (1) DE69712610T2 (ko)
DK (1) DK0885234T3 (ko)
EA (1) EA001376B1 (ko)
EE (1) EE9800265A (ko)
ES (1) ES2176698T3 (ko)
FR (1) FR2745290B1 (ko)
HU (1) HU227567B1 (ko)
IL (1) IL125622A (ko)
NO (1) NO983955L (ko)
NZ (1) NZ331600A (ko)
OA (1) OA10845A (ko)
PL (1) PL191736B1 (ko)
PT (1) PT885234E (ko)
SK (1) SK118498A3 (ko)
TR (1) TR199801713T2 (ko)
UA (1) UA58504C2 (ko)
WO (1) WO1997031929A1 (ko)
YU (1) YU37098A (ko)
ZA (1) ZA971659B (ko)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004514643A (ja) * 1997-10-29 2004-05-20 大正製薬株式会社 エリスロマイシンａ誘導体
AU9649598A (en) * 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a, 11,12-carbamate derivatives
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2780977B1 (fr) * 1998-07-09 2000-09-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2792637B1 (fr) * 1999-04-26 2001-06-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2781484B1 (fr) 1998-07-21 2001-08-10 Hoechst Marion Roussel Inc Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
BR9916969A (pt) 1999-01-27 2001-11-06 Pfizer Prod Inc Antibióticos cetólidos
WO2000071557A1 (en) * 1999-05-24 2000-11-30 Pfizer Products Inc. 13-methyl-erythromycin derivatives
WO2001010880A1 (fr) * 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
AU6316400A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
WO2001010878A1 (fr) * 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
CA2529817C (en) 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007069264A2 (en) * 2005-12-15 2007-06-21 Alembic Limited Reference standards for determining the purity of telithromycin and processes therefor
CN101917850B (zh) 2007-10-25 2016-01-13 森普拉制药公司 大环内酯类抗菌剂的制备方法
WO2010048599A1 (en) 2008-10-24 2010-04-29 Cempra Pharmaceuticals, Inc. Methods for treating gastrointestinal diseases
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ，インコーポレイテッド マラリア、結核、及びｍａｃ病の治療方法
NZ602544A (en) 2010-03-22 2014-11-28 Cempra Pharmaceuticals Inc Crystalline forms of a macrolide, and uses therefor
US9051346B2 (en) 2010-05-20 2015-06-09 Cempra Pharmaceuticals, Inc. Process for preparing triazole-containing ketolide antibiotics
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
SG11201405895UA (en) 2012-03-27 2014-10-30 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
US9861616B2 (en) 2013-03-14 2018-01-09 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
JP6675973B2 (ja) 2013-03-15 2020-04-08 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライド抗菌薬を調製するための集束的な方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US487411A (en) * 1892-12-06 Island
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5444031A (en) * 1993-01-21 1995-08-22 Calgon Carbon Corporation Process for making catalytic carbon
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
CN1168734C (zh) 2004-09-29
AP952A (en) 2001-03-29
ZA971659B (en) 1998-02-26
IL125622A0 (en) 1999-04-11
EA199800768A1 (ru) 1999-02-25
HU227567B1 (en) 2011-08-29
CZ293893B6 (cs) 2004-08-18
AR005999A1 (es) 1999-07-21
EE9800265A (et) 1999-02-15
KR19990087324A (ko) 1999-12-27
ES2176698T3 (es) 2002-12-01
JP4102440B2 (ja) 2008-06-18
FR2745290A1 (fr) 1997-08-29
US6096714A (en) 2000-08-01
OA10845A (fr) 2003-02-05
BR9707709A (pt) 1999-04-06
HUP9902576A3 (en) 2001-03-28
DE69712610T2 (de) 2002-11-28
KR100486053B1 (ko) 2005-06-16
WO1997031929A1 (fr) 1997-09-04
EA001376B1 (ru) 2001-02-26
BG63207B1 (bg) 2001-06-29
EP0885234B1 (fr) 2002-05-15
DK0885234T3 (da) 2002-08-26
NO983955D0 (no) 1998-08-27
UA58504C2 (uk) 2003-08-15
ATE217633T1 (de) 2002-06-15
FR2745290B1 (fr) 1998-04-03
YU37098A (sh) 1999-07-28
NZ331600A (en) 1999-08-30
BG102691A (en) 1999-06-30
AP9801318A0 (en) 1998-09-30
BR9707709B1 (pt) 2014-10-14
AU1929897A (en) 1997-09-16
JP2000505469A (ja) 2000-05-09
DE69712610D1 (de) 2002-06-20
PT885234E (pt) 2002-10-31
NO983955L (no) 1998-08-27
TR199801713T2 (xx) 1998-12-21
PL191736B1 (pl) 2006-06-30
AU716204B2 (en) 2000-02-24
HUP9902576A1 (hu) 1999-12-28
CN1212700A (zh) 1999-03-31
PL328608A1 (en) 1999-02-01
SK118498A3 (en) 1999-07-12
EP0885234A1 (fr) 1998-12-23
CZ258798A3 (cs) 1998-12-16

Similar Documents

Publication Publication Date Title
IL125622A (en) Erythromycin derivatives, method for preparing same and pharmaceutical compositions comprising them
HUT73772A (en) Novel erythromycin derivatives, method for preparing same and pharmaceutical compositions containing the same
HU9603038D0 (en) Novel erythromycin derivatives, method for their preparation and their use as drugs
HUP0100431A3 (en) Adamantana derivatives, pharmaceutical compositions comprising them and process for preparing them
HUP9700358A3 (en) New oxazolidinon derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9900056A2 (hu) Szubsztituált 4-fenil-amino-tiazol-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények
HUP0002252A3 (en) 9-oxime erythromycin derivatives, process for preparing them and pharmaceutical compositions containing them
IL127798A (en) N-substituted indol-3-glyoxylamides, process for their preparation and pharmaceutical compositions comprising them
HUP0001555A3 (en) Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
HUP0002424A3 (en) Hydrazine derivatives, pharmaceutical compositions comprising them, and method for producing them
HUP0003267A3 (en) Heteroaryl derivatives, pharmaceutical compositions containing them and process for producing them
HUP0102602A3 (en) Diacylhydrazine derivatives, method for their preparation, their use and pharmaceutical compositions comprising thereof
HUP9901739A3 (en) Aminoisoquinolines and aminothienopyridine derivatives, process for producing thereof and pharmaceutical compositions containing them
HUP0104035A3 (en) Novel erythromycin derivatives, preparation method and use as medicines
HUP0103316A3 (en) 2-ureido-pyrimidone derivatives, method for producing them, pharmaceutical compositions containing them and their use
HUT75112A (en) Oxathiolanes, method for their preparation and pharmaceutical compositions contating same
NZ328979A (en) Ring-contracted n-demethyl-n-isopropyl-spiroacetyl derivatives of erythromycin a (10,13,15-trioxatricyclo [9.2.1.1 9.6] -pentadecanone derivatives), method of preparation and pharmaceutical compositions thereof
HUP0101234A3 (en) Betha-carboline derivatives, process for their preparation and pharmaceutical compositions thereof
HUP9903424A3 (en) Novel erythromycin derivatives,method for preparing same and use thereof as drugs
HUP0100342A3 (en) Novel acronycine derivatives, preparation method and pharmaceutical compositions
IL130420A (en) Erythromycin derivatives, method for preparing them and their use as medicine
NZ329271A (en) 4-benzyl-piperidin-4-ol derivatives, preparation and pharmaceutical compositions thereof
HUP0001183A3 (en) Pyrrolothiazine and pyrrolothiazepine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0001222A3 (en) Imino-aza-anthracyclinone derivatives, pharmaceutical compositions thereof against amyloidosis and process for preparing them
HUP9904526A3 (en) Piperidine derivatives, process for their preparation and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired